Tenaya Therapeutics, Inc. (TNYA) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 6 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for TNYA is $2.33, representing a +215.3% upside from the current price of $0.739. Price targets range from a low of $2.00 to a high of $3.00.
